FDA Amends Joint Meeting Notice of Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee

Summary

The FDA is updating a notice for a joint meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee, first announced in 2010, to reflect changes to the meeting agenda.